Granite Bay Wealth Management LLC Makes New $290,000 Investment in Astrana Health, Inc. (NASDAQ:ASTH)

Granite Bay Wealth Management LLC acquired a new position in shares of Astrana Health, Inc. (NASDAQ:ASTHFree Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 5,000 shares of the company’s stock, valued at approximately $290,000.

Separately, Central Pacific Bank Trust Division purchased a new position in shares of Astrana Health in the third quarter valued at $160,000. Institutional investors own 52.77% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ASTH. Robert W. Baird upped their target price on shares of Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a research note on Thursday, August 15th. BTIG Research upped their target price on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday. Stifel Nicolaus upped their target price on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. Finally, Truist Financial upped their target price on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $61.20.

Read Our Latest Stock Report on Astrana Health

Astrana Health Trading Up 2.8 %

ASTH opened at $59.48 on Friday. The stock has a market capitalization of $3.33 billion, a PE ratio of 45.06, a P/E/G ratio of 2.15 and a beta of 1.20. The firm’s fifty day moving average price is $50.97 and its 200 day moving average price is $44.40. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.84 and a quick ratio of 1.84. Astrana Health, Inc. has a 12-month low of $28.86 and a 12-month high of $59.89.

Astrana Health (NASDAQ:ASTHGet Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.01. The firm had revenue of $486.30 million for the quarter, compared to analysts’ expectations of $440.68 million. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The firm’s quarterly revenue was up 39.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.28 earnings per share. As a group, research analysts expect that Astrana Health, Inc. will post 1.33 EPS for the current fiscal year.

Astrana Health Profile

(Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTHFree Report).

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.